These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bronchogenic carcinoma in situ in asymptomatic high-risk population of smokers. Valaitis J, McGrew EA, Chomet B, Correll N, Head J. J Thorac Cardiovasc Surg; 1969 Mar; 57(3):325-32. PubMed ID: 5773201 [No Abstract] [Full Text] [Related]
7. Should patients with haemoptysis and a normal chest X-ray be bronchoscoped? Heaton RW. Postgrad Med J; 1987 Nov; 63(745):947-9. PubMed ID: 3451216 [Abstract] [Full Text] [Related]
8. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Poe RH, Israel RH, Marin MG, Ortiz CR, Dale RC, Wahl GW, Kallay MC, Greenblatt DG. Chest; 1988 Jan; 93(1):70-5. PubMed ID: 3335170 [Abstract] [Full Text] [Related]
12. Lung cancer cell type as a determinant of bronchoscopy yield. Zisholtz BM, Eisenberg H. Chest; 1983 Oct; 84(4):428-30. PubMed ID: 6311489 [Abstract] [Full Text] [Related]
13. Positive sputum cytologic tests for five years before specific detection of bronchial carcinoma. Meyer JA, Bechtold E, Jones DB. J Thorac Cardiovasc Surg; 1969 Mar; 57(3):318-24. PubMed ID: 5773200 [No Abstract] [Full Text] [Related]
14. Bronchoscopy to evaluate hemoptysis in older men with nonsuspicious chest roentgenograms. Lederle FA, Nichol KL, Parenti CM. Chest; 1989 May; 95(5):1043-7. PubMed ID: 2539956 [Abstract] [Full Text] [Related]
17. Role of fiberoptic bronchoscopy in patients with hemoptysis and a normal chest roentgenogram. Jackson CV, Savage PJ, Quinn DL. Chest; 1985 Feb; 87(2):142-4. PubMed ID: 3967521 [Abstract] [Full Text] [Related]
18. Value of sputum cytology in the diagnosis and typing of bronchogenic carcinomas, excluding adenocarcinomas. Gupta RK. Acta Cytol; 1982 Feb; 26(5):645-8. PubMed ID: 6959454 [Abstract] [Full Text] [Related]